Joshua Hare net worth and biography

Joshua Hare Biography and Net Worth

Insider of Longeveron
Dr. Hare co-founded Longeveron in 2014 and serves as Chairman of the Board of Directors, and Chief Science Officer. Dr. Hare is a double board-certified cardiologist (Cardiology and Advanced Heart Failure and Transplantation) and is the founding director of the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine. He has obtained in excess of $25 Million in funding from the National Institutes of Health over the past 15 years to support basic research of cell therapy strategies. He is also a recipient of the Paul Beeson Physician Faculty Scholar in Aging Research Award, and is an elected member of the American Association of Physicians, The American Society for Clinical Investigation, and is an elected Fellow of the American Heart Association. Dr. Hare has also served in numerous leadership roles at the American Heart Association and at the Center for Scientific Review of the National Institutes of Health. Dr. Hare is also a co-founder of Vestion, Inc., and Heart Genomics, LLC, companies that hold cardio-related intellectual property. He received a BA from the University of Pennsylvania, and his MD from The Johns Hopkins University School of Medicine, and completed fellowships at Johns Hopkins and Brigham and Women’s Hospital, and was a Research Fellow at Harvard Medical School.

What is Joshua Hare's net worth?

The estimated net worth of Joshua Hare is at least $31.97 million as of April 18th, 2022. Dr. Hare owns 7,913,341 shares of Longeveron stock worth more than $31,969,898 as of September 26th. This net worth evaluation does not reflect any other assets that Dr. Hare may own. Additionally, Dr. Hare receives a salary of $449,810.00 as Insider at Longeveron. Learn More about Joshua Hare's net worth.

How old is Joshua Hare?

Dr. Hare is currently 59 years old. There are 4 older executives and no younger executives at Longeveron. Learn More on Joshua Hare's age.

What is Joshua Hare's salary?

As the Insider of Longeveron Inc., Dr. Hare earned a total compensation package of $1,324,923.00 in 2021. Dr. Hare earned a salary of $265,575.00, a bonus of $132,240.00, stock awards of $621,108.00, options awards of $266,000.00, and other compensation of $40,000.00.There are 2 executives that earn more than Dr. Hare. The highest earning executive at Longeveron is Mr. James Clavijo CPA, CFO & Treasurer, who commands a salary of $481,070.00 per year. Learn More on Joshua Hare's salary.

How do I contact Joshua Hare?

The corporate mailing address for Dr. Hare and other Longeveron executives is 1951 NW 7TH AVENUE SUITE 520, MIAMI FL, 33136. Longeveron can also be reached via phone at 305-909-0840 and via email at [email protected] Learn More on Joshua Hare's contact information.

Has Joshua Hare been buying or selling shares of Longeveron?

Joshua Hare has not been actively trading shares of Longeveron during the last ninety days. Most recently, Joshua Hare sold 19,922 shares of the business's stock in a transaction on Monday, April 18th. The shares were sold at an average price of $10.00, for a transaction totalling $199,220.00. Following the completion of the sale, the insider now directly owns 7,913,341 shares of the company's stock, valued at $79,133,410. Learn More on Joshua Hare's trading history.

Who are Longeveron's active insiders?

Longeveron's insider roster includes James Clavijo (CFO), Geoff Green (CEO), Joshua Hare (Insider), Paul Lehr (General Counsel), and Rock Soffer (Director). Learn More on Longeveron's active insiders.

Are insiders buying or selling shares of Longeveron?

During the last year, Longeveron insiders bought shares 7 times. They purchased a total of 28,135 shares worth more than $100,864.30. During the last year, insiders at the sold shares 4 times. They sold a total of 72,377 shares worth more than $627,158.30. The most recent insider tranaction occured on June, 3rd when CFO James Clavijo sold 36,955 shares worth more than $305,248.30. Insiders at Longeveron own 41.6 % of the company. Learn More about insider trades at Longeveron.

Information on this page was last updated on 6/3/2022.

Joshua Hare Insider Trading History at Longeveron

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/18/2022Sell19,922$10.00$199,220.007,913,341View SEC Filing Icon  
10/12/2021Buy2,500$3.69$9,225.00View SEC Filing Icon  
10/7/2021Buy1,985$3.38$6,709.30View SEC Filing Icon  
See Full Table

Joshua Hare Buying and Selling Activity at Longeveron

This chart shows Joshua Hare's buying and selling at Longeveron by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Longeveron Company Overview

Longeveron logo
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.
Read More

Today's Range

Now: $4.04
Low: $3.89
High: $4.07

50 Day Range

MA: $5.44
Low: $3.97
High: $6.77

2 Week Range

Now: $4.04
Low: $2.84
High: $45.00

Volume

39,500 shs

Average Volume

2,072,154 shs

Market Capitalization

$84.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.04
Finally... Some Good News
This "World's Most Admired" company's stock is under $2!

Click to Watch the FREE Presentation
>>>
pixel